(Q40471639)

20 September 2017

Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. (English)

1 reference

20 September 2017

Karen L Hardinger

1

1 reference

20 September 2017

Daniel C Brennan

series ordinal

2

1 reference

20 September 2017

Jeffrey Lowell

series ordinal

3

1 reference

20 September 2017

Mark A Schnitzler

series ordinal

4

1 reference

20 September 2017

29 October 2004

1 reference

20 September 2017

Transplant International

1 reference

20 September 2017

17

1 reference

20 September 2017

609-616

1 reference

20 September 2017

10

1 reference

Prophylaxis and treatment of gastrointestinal complications following transplantation

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant-induced gastrointestinal toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

The use of mycophenolate mofetil in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

Immunosuppressive therapy and post-transplantation diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

Diabetes mellitus after kidney transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait-Listed and Transplanted Renal Allograft Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

The Association of Cytomegalovirus Sero-Pairing with Outcomes and Costs Following Cadaveric Renal Transplantation Prior to the Introduction of Oral Ganciclovir CMV Prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

INTESTINAL MICROSPORIDIOSIS OCCURRING IN TWO RENAL TRANSPLANT RECIPIENTS TREATED WITH MYCOPHENOLATE MOFETIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.TB00394.X

10.1111/J.1432-2277.2004.TB00394.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference